Researchers at University of Tsukuba have achieved high-resolution visualization of cellular organelles, such as nuclei and ...

X-ray phase-contrast imaging techniques have emerged as a powerful supplement to conventional absorption-based methods, allowing researchers and clinicians to visualise soft tissues and subtle ...

Introduction Chronic kidney disease (CKD) affects 1 in 10 people worldwide and can progress towards kidney failure, which is ...

Techniques that exploit the phase of X-rays, not just their absorption, have the potential to transform X-ray imaging in hospitals, reports Jude Dineley Improved imaging Marian Willner from the ...

A new publication from Opto-Electronic Advances; DOI 10.29026/oea.2024.240060, discusses multi-prior intelligent microscopy assisted high-throughput, pixel super-resolution quantitative phase imaging.

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent ...

Scientists at the University of Birmingham have developed a new class of MRI contrast agents, improving their stability to ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. Data from the first-in-human trial – presented at ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Heart failure (HF) is a clinical syndrome with a wide variety of clinical presentations, pathophysiologies ...

Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...